Patrick R. O'Neil
CIK 1564926 · EVP CLO & General Counsel · last filed 2026-09-02
Patrick R. O'Neil is an EVP CLO & General Counsel who has filed 131 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for IONS, was dated Sep 2, 2026. Across all open-market trades the lifetime net is −$35.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions. 138 SEC filings were submitted jointly with IONIS PHARMACEUTICALS INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IONS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2855 GAZELLE COURT
CARLSBAD, CA 92010
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP CLO & General Counsel | 59,205 | $40.15 | $2.38M | -$30.73M | 84 | 2026-09-02 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Legal & General Counsel | 7,259 | — | — | -$5.16M | 29 | 2015-12-02 |
Recent Filings
131 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-02 | IONS | Other (J) | +63 | $3.2K | EDGAR |
| 2026-06-26 | IONS | Notice (144) | −3,069 | -$245.5K | EDGAR |
| 2026-03-11 | IONS | Sell (S) | −10,148 | -$763.7K | EDGAR |
| 2026-03-09 | IONS | Notice (144) | −13,217 | -$994.6K | EDGAR |
| 2026-03-03 | IONS | Other (J) | +376 | $18.4K | EDGAR |
| 2026-02-02 | IONS | Mixed | +5,812 | -$516.2K | EDGAR |
| 2026-01-30 | IONS | Notice (144) | −6,179 | -$512.9K | EDGAR |
| 2026-01-20 | IONS | Mixed | +12,282 | -$697.0K | EDGAR |
| 2026-01-16 | IONS | Notice (144) | −9,191 | -$700.6K | EDGAR |
| 2026-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.